Skip to content

Gait Modifications and Cutaneous Stimulation

Analysis of Joint Mechanics in Response to Gait Modifications and Cutaneous Stimulation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02884414
Enrollment
56
Registered
2016-08-31
Start date
2016-08-31
Completion date
2019-02-28
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

Knee Pathology

Brief summary

The purpose of this study is to quantify differences in joint mechanics between different types of walking in healthy individuals and individuals with knee pathology. The investigators will determine how modifying gait through feedback and/or cutaneous stimulation changes joint loading.

Interventions

A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI \< 35 kg/m\^2 * For knee pathology subjects: Diagnosis of knee pathology (e.g. knee osteoarthritis, ACL injury, etc) and/or knee pain * Full weight-bearing status

Exclusion criteria

* Non-ambulatory * Use of walking aid * For healthy volunteers - history of surgical intervention at any joint of the lower extremity * Inability to cooperate with study protocol due to medical or psychiatric reasons * Inability to provide informed consent * For healthy subjects: Any diagnosis of knee osteoarthritis or knee pain

Design outcomes

Primary

MeasureTime frameDescription
Change in Peak Knee Flexion Moment (%Bw*Ht)ImmediateWithin-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).

Countries

United States

Participant flow

Participants by arm

ArmCount
Cutaneous Stimulation
Cutaneous stimulation and/or feedback. This stimulation and/or feedback may be visual, auditory, tactile (e.g. vibratory, temperature), or haptic and is completely external. Cutaneous stimulation: A non-invasive external device that will be placed on the leg of the subject. The device consists of a sensing module to determine specific points in the gait cycle, a processor to analyze signal from the sensor, and a stimulus module to provide feedback to the subject.
56
Total56

Baseline characteristics

CharacteristicCutaneous Stimulation
Age, Continuous47.8 years
STANDARD_DEVIATION 18.5
Knee Flexion Moment2.68 %Bw*Ht
STANDARD_DEVIATION 1.29
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
17 Participants
Race (NIH/OMB)
Black or African American
2 Participants
Race (NIH/OMB)
More than one race
1 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
36 Participants
Region of Enrollment
United States
56 participants
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 56
other
Total, other adverse events
0 / 56
serious
Total, serious adverse events
0 / 56

Outcome results

Primary

Change in Peak Knee Flexion Moment (%Bw*Ht)

Within-subject change in peak knee flexion moment (%Bodyweight\*Height) with the intervention versus control (without the intervention).

Time frame: Immediate

ArmMeasureValue (MEAN)Dispersion
Cutaneous StimulationChange in Peak Knee Flexion Moment (%Bw*Ht)2.72 %Bw*HtStandard Deviation 1.25
p-value: 0.44t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026